The/DT
human/JJ
myelomonocytic/JJ
cell/NN
line/NN
U-937/NN
as/IN
a/DT
model/NN
for/IN
studying/VBG
alterations/NNS
in/IN
steroid-induced/JJ
monokine/NN
gene/NN
expression/NN
:/:
marked/JJ
enhancement/NN
of/IN
lipopolysaccharide-stimulated/JJ
interleukin-1/NN
beta/NN
messenger/NN
RNA/NN
levels/NNS
by/IN
1,25-dihydroxyvitamin/NN
D3/NN
./.

The/DT
active/JJ
metabolite/NN
of/IN
vitamin/NN
D/NN
,/,
1,25-dihydroxyvitamin/NN
D3/NN
[/(
1,25-(OH)2D3/NN
]/)
,/,
is/VBZ
a/DT
potent/JJ
regulator/NN
of/IN
human/JJ
monocyte/macrophage/JJ
function/NN
in/FW
vitro/FW
./.
=====
To/TO
establish/VB
a/DT
model/NN
for/IN
1,25-(OH)2D3/NN
regulation/NN
of/IN
human/JJ
monocyte/NN
monokine/NN
synthesis/NN
,/,
three/CD
human/JJ
cell/NN
lines/NNS
(/(
U-937/NN
,/,
THP-1/NN
,/,
and/CC
HL-60/NN
)/)
were/VBD
examined/VBN
for/IN
:/:
1/LS
)/)
the/DT
presence/NN
of/IN
functional/JJ
1,25-(OH)2D3/NN
receptors/NNS
;/:
2/LS
)/)
the/DT
accumulation/NN
of/IN
interleukin-1/NN
beta/NN
(/(
IL-1/NN
beta/NN
)/)
mRNA/NN
and/CC
IL-1/NN
beta/NN
protein/NN
in/IN
response/NN
to/TO
lipopolysaccharide/NN
(/(
LPS/NN
)/)
;/:
and/CC
3/LS
)/)
the/DT
regulation/NN
of/IN
this/DT
response/NN
by/IN
1,25-(OH)2D3/NN
./.
=====
All/DT
three/CD
cell/NN
lines/NNS
expressed/VBD
vitamin/NN
D/NN
receptor/NN
and/CC
had/VBD
increased/VBN
levels/NNS
of/IN
IL-1/NN
beta/NN
mRNA/NN
in/IN
response/NN
to/TO
LPS/NN
./.
=====
Preincubation/NN
of/IN
cells/NNS
with/IN
1,25-(OH)2D3/NN
augmented/VBD
IL-1/NN
beta/NN
mRNA/NN
levels/NNS
only/RB
in/IN
U-937/NN
and/CC
HL-60/NN
cells/NNS
./.
=====
From/IN
these/DT
data/NNS
,/,
and/CC
taking/VBG
into/IN
consideration/NN
their/PRP$
state/NN
of/IN
differentiation/NN
and/CC
relative/JJ
ease/NN
of/IN
culture/NN
,/,
U-937/NN
was/VBD
chosen/VBN
over/IN
HL-60/NN
and/CC
THP-1/NN
as/IN
the/DT
cell/NN
line/NN
we/PRP
further/RB
characterized/VBD
./.
=====
In/IN
U-937/NN
cells/NNS
,/,
optimum/JJ
time/NN
and/CC
dose/NN
of/IN
pretreatment/NN
with/IN
1,25-(OH)2D3/NN
were/VBD
determined/VBN
to/TO
be/VB
12-24/CD
h/NN
at/IN
a/DT
receptor/NN
saturating/JJ
concentration/NN
of/IN
1,25-(OH)2D3/NN
(/(
10/CD
nM/NN
)/)
./.
=====
Preincubation/NN
of/IN
cells/NNS
with/IN
1,25-(OH)2D3/NN
had/VBD
no/DT
effect/NN
on/IN
the/DT
time/NN
course/NN
of/IN
IL-1/NN
beta/NN
mRNA/NN
appearance/NN
in/IN
response/NN
to/TO
LPS/NN
./.
=====
However/RB
,/,
exposure/NN
of/IN
U-937/NN
cells/NNS
to/TO
1,25-(OH)2D3/NN
increased/VBD
by/IN
200/CD
%/NN
the/DT
level/NN
of/IN
IL-1/NN
beta/NN
mRNA/NN
detected/VBD
and/CC
decreased/VBD
by/IN
three/CD
orders/NNS
of/IN
magnitude/NN
the/DT
concentration/NN
of/IN
LPS/NN
required/VBN
to/TO
achieve/VB
steady/JJ
state/NN
mRNA/NN
levels/NNS
equivalent/JJ
to/TO
those/DT
observed/VBN
in/IN
U-937/NN
cells/NNS
not/RB
preincubated/VBN
with/IN
the/DT
hormone.2+o/NN